Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
Go back to Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat| Johnson & Johnson (NYSE: JNJ) | Delayed: 259.62 -2.46 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.08 | 52 Week High | $126.07 | |||
| Open | $260.65 | 52 Week Low | $94.28 | |||
| Day High | $261.71 | P/E | 53.98 | |||
| Day Low | $259.62 | EPS | $4.81 | |||
| Volume | 752,530 | |||||

